You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...

A clinical trial testing two drugs against the Bundibugyo ebolavirus, which is driving a fast-moving outbreak in Central ...

The Tarasoff case remains a pivotal marker in bioethics at the bicentennial as we now reach the country’s 250th birthday.

Women are fully capable of making difficult decisions, but meaningful choice requires trusted, vetted information,” writes ...

A judge temporarily blocked federal prosecutors in Texas from getting access to the medical records of transgender patients ...

RIP Sangamo, onshoring with drug manufacturing, and more biotech news from The Readout ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

The Justice Department has charged a Texas doctor in an $89 million health care fraud scheme, accusing him of billing ...

Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental ...

Eli Lilly is investing in a small startup developing a medication to spur hair growth, and potentially also treat endometriosis.

Regenxbio plans to submit its Duchenne gene therapy for FDA approval, just a month after it said that regulators wanted to ...

Digital health startup Cadence has raised $100 million at a $1.23 billion valuation to expand its chronic disease management ...